Pharmacology for Nurses · Drugs to Treat Myasthenia Gravis and Alzheimer’s Disease

Introduction to Alzheimer’s Disease

9 min read
Safety note: Educational draft only — no doses, schedules, or treatment recommendations are provided. Diagnosis and management of dementia vary by specialist, institution, and current evidence; always verify against current references, the formulary, and prescriber orders.
Want it in plain words first? Jump to Eli explains — the same idea, no jargon.
On this page 9 sections
  1. In 30 seconds
  2. Why this matters
  3. The college version
  4. Eli explains
  5. Worked example
  6. Key takeaway
  7. Check yourself
  8. Study tools
  9. Sources & references

In 30 seconds

(AD) is a progressive neurodegenerative disorder and the most common cause of — the general term for decline in memory, thinking, and daily function severe enough to interfere with independent living. In AD, characteristic changes accumulate over many years: protein clumps called amyloid plaques form between neurons, twisted strands of tau form neurofibrillary tangles inside neurons, and populations of neurons — especially the cholinergic neurons that use acetylcholine — progressively die. The result is brain atrophy, particularly in memory-critical areas such as the , and gradual loss of cognitive and functional abilities.

AD has a slow onset and a long course. It typically begins with subtle short-term memory problems and advances over years through stages of increasing dependence. Because loss is a central and early feature, much of the drug therapy in this chapter — the acetylcholinesterase inhibitors — is designed to compensate for it, which is why the chapter pairs the disease with its pharmacology.

Why this matters

Dementia — and AD as its most common cause — is one of the defining health challenges of aging populations, and nurses encounter people with AD in nearly every setting: medical units, long-term care, home health, emergency departments, and hospice. Beyond pharmacology, AD demands skilled nursing in safety (falls, wandering, getting lost), communication as language declines, caregiver support, and dignity (person-first, person-centered care). Recognizing the difference between normal aging, , and dementia — and between dementia and depression, which can mimic it — is a core assessment skill. For exams, AD is high-yield for its pathology, clinical stages, and the mechanism of the drug classes that follow.

The college version

Core Concepts

Normal aging, mild cognitive impairment, and dementia

Not every memory slip is dementia. Normal aging may bring slower recall, but daily function is preserved. is a measurable decline greater than expected for age that does not yet disrupt daily life; people with MCI are at increased risk of progressing to dementia, though many do not. Dementia is the step beyond: cognitive decline that does interfere with independence. AD is one specific cause; others include vascular dementia, Lewy body dementia, and frontotemporal disorders. The nurse describes what the person can and cannot do; diagnosis belongs to the provider.

The pathology of Alzheimer's disease

Two hallmark lesions define AD under the microscope. Amyloid plaques are extracellular deposits of beta-amyloid between neurons, thought to contribute to synaptic damage. Neurofibrillary tangles are intracellular accumulations of hyperphosphorylated tau that disrupt the neuron's internal transport and correlate with cell death. Alongside these, there is progressive synaptic and neuronal loss, most prominent in the hippocampus and cerebral cortex, and a striking loss of cholinergic neurons projecting from the basal forebrain — the basis for the cholinergic hypothesis and the AChE-inhibitor drug class. No single mechanism fully explains AD; it is understood as a multifactorial process.

Risk factors and the genetics of risk

The strongest risk factor is age. Family history increases risk, and a small fraction of cases are caused by rare inherited mutations producing early-onset disease. The best-studied genetic risk factor for the common, late-onset form is the allele, which increases risk but does not guarantee the disease — many carriers never develop AD. Modifiable factors associated with lower dementia risk include cardiovascular health, physical activity, and social and cognitive engagement. These are associations from population research, not promises.

The clinical course: stages of AD

AD unfolds gradually, and stage boundaries blur:

  • Early: subtle short-term memory loss (repeating questions, forgetting recent events), difficulty finding words, mood changes. The person often still lives independently with support.
  • Middle: more obvious decline — getting lost in familiar places, difficulty with dressing or finances, and behavioral changes such as agitation, suspicion, or wandering. Safety risks rise sharply.
  • Late: severe impairment; help needed with all activities of daily living; may lose coherent speech, become incontinent, and have difficulty swallowing. Care focuses on comfort and dignity.

The pace varies widely between individuals, so care plans must be individualized and reassessed regularly.

Diagnosis and the rule-out process

There is no single blood test that diagnoses AD. Providers build the diagnosis from a careful history — including collateral history from family, essential because the person may not recognize their own decline — plus cognitive screening, laboratory tests to rule out reversible causes (such as thyroid disease or vitamin B12 deficiency), and brain imaging to look for stroke or tumors. Emerging biomarkers (amyloid imaging or CSF measures of amyloid and tau) support diagnosis in specialized settings. Delirium, depression, and medication effects must be excluded — all three can masquerade as dementia.

Care beyond medications

Pharmacology is only part of the picture. Person-centered care includes predictable routines and a calm environment; clear, simple communication with validation rather than correction; safety measures for wandering, falls, and unsafe driving; support for nutrition, hydration, and sleep; and — critically — caregiver education and support. Non-pharmacologic strategies are the first-line approach for many behavioral symptoms, which are understood as communication of unmet needs (pain, hunger, boredom, overstimulation). The nursing goal is to see the whole person and the whole family.

Common Confusions

Do Not ConfuseWithDifference
Normal agingDementiaAging may slow recall; dementia disrupts daily function and worsens over time
DeliriumDementiaDelirium is acute, fluctuating, often reversible (infection, medications); dementia is gradual and progressive — different emergencies, different management
DementiaAlzheimer's diseaseDementia is the umbrella term; AD is one specific cause (the most common)
Amyloid plaquesNeurofibrillary tanglesPlaques sit between neurons (beta-amyloid); tangles form inside neurons (tau)
"A diagnosis of AD""A definitive, simple test for AD"Diagnosis is clinical plus rule-out testing; biomarkers support it in specialized settings
APOE ε4 = "has the gene"APOE ε4 = "will get AD"The allele raises risk; many carriers never develop AD
Eli, the EliExplains learning guide

Eli explains

The same idea, in plain words

Explain it like I’m 10

Alzheimer's disease is like a library where some books slowly get lost, and the librarian who files new memories gets sick. First the new books (new memories) get misplaced, and later even old favorites fade. The brain's special memory messengers — neurons that use acetylcholine — are among the first to wear out. Medicines can't rebuild the library, but some can help the remaining messengers work a little better for a while. That's why the drugs help some people a bit but don't cure the disease.

Worked example

A daughter calls the primary care office about her 78-year-old mother. Over the past year, her mother has repeated the same questions within minutes, forgotten appointments, and recently left the stove on. The mother insists her memory is fine. The daughter asks, "Is this just getting older?" A nurse who understands AD recognizes this as a classic presentation — progressive short-term memory loss reported by a family member, with preserved social skills that can mask the decline. The nurse arranges an evaluation that includes the mother and the daughter's observations (collateral history), a medication review (some medicines cause confusion), blood work to rule out thyroid disease and B12 deficiency, and a cognitive assessment. The provider rules out delirium (gradual, not acute onset) and depression. Probable Alzheimer's disease is discussed with the family, and the care conversation begins: home support, safety measures, and what to expect over time.

Key takeaways

  • AD = progressive neurodegenerative disease; the most common cause of dementia. Dementia = cognitive decline that interferes with daily function; AD is one specific cause.
  • Hallmark pathology: amyloid plaques (outside neurons) and tau neurofibrillary tangles (inside neurons), plus neuronal/synaptic loss and brain atrophy.
  • Cholinergic neuron loss is central — the rationale for acetylcholinesterase inhibitor therapy.
  • Hippocampus = memory hub; affected early — explains why short-term memory loss is the classic first symptom.
  • Age is the strongest risk factor; APOE ε4 increases risk but does not cause or guarantee the disease.
  • Rule out reversible causes: delirium, depression, thyroid disease, B12 deficiency, medications — all can mimic dementia.
  • Course is staged (early/middle/late) but highly individual; safety and function, not just cognition, drive care planning.
  • Nursing anchors: collateral history, safety assessment (wandering, falls, driving), swallow and nutrition monitoring, behavioral expressions as communication, caregiver support, person-first care.

Check yourself

6 review questions from the chapter. Try each one, then open the answer.

  1. What is the difference between dementia and Alzheimer's disease?

    Show answer

    Dementia is the umbrella term for cognitive decline that interferes with daily function. Alzheimer's disease is a specific disease — the most common cause of dementia — defined by characteristic progressive pathology. Not all dementia is AD.

  2. Name the two hallmark pathological lesions of AD and where each is located.

    Show answer

    Amyloid plaques — extracellular beta-amyloid deposits between neurons. Neurofibrillary tangles — intracellular tau accumulations inside neurons.

  3. Why is short-term memory loss typically the first noticeable symptom of AD?

    Show answer

    Because the hippocampus, the brain structure most responsible for forming new memories, is among the earliest and most severely affected regions in AD. New information cannot be consolidated into lasting memory, so recent events and new learning fail first, while older memories are relatively preserved until later.

  4. A hospitalized person becomes acutely confused overnight with fluctuating attention. Is this more consistent with dementia or delirium, and why does it matter?

    Show answer

    Delirium — acute onset and fluctuating attention are its signatures. This matters because delirium is often caused by a reversible medical problem (infection, medication, electrolyte disturbance, hypoxia) and is potentially treatable if found fast, whereas dementia is progressive. New confusion in a hospitalized person is treated as a medical emergency until proven otherwise.

  5. What is the role of the cholinergic system in AD, and how does it connect to drug therapy?

    Show answer

    Cholinergic neurons originating in the basal forebrain are selectively lost in AD, reducing acetylcholine signaling in regions supporting memory and attention. Acetylcholinesterase inhibitors compensate by slowing the breakdown of the acetylcholine that remains, modestly supporting cognition — they do not stop the underlying neuron loss.

  6. Why is collateral history from family essential in evaluating a person for possible dementia?

    Show answer

    Because the person with dementia frequently cannot report their own decline — insight is often impaired, and social skills may mask deficits. Family and caregivers provide the timeline, examples of functional change, and safety information that convert "seems fine" into a recognizable, evaluable pattern.

Keep learning

Ready to build on this? Continue to the next lesson.

Study tools & related lessonsKey vocabulary · Related

Key vocabulary

Dementia
Decline in memory, thinking, and function that interferes with daily life
Alzheimer's disease
The most common specific cause of dementia, with characteristic brain pathology
Amyloid plaque
Extracellular clump of beta-amyloid between neurons
Neurofibrillary tangle
Intracellular tangle of tau protein inside neurons
Hippocampus
Brain structure central to forming new memories
Cholinergic neuron
A neuron that releases acetylcholine
Mild cognitive impairment (MCI)
Measurable cognitive decline that does not yet disrupt daily function
Delirium
Acute, fluctuating confusion, often with a medical cause
APOE ε4
A genetic variant that increases dementia risk

Sources & references

  1. openstax.org — Pharmacology

This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.

Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.